|
Angiopoietin-2
|
D12.776.467.100.100.200 |
|
|
Angiopoietins
|
D12.776.467.100.100 |
|
|
Adrenergic beta-2 Receptor Agonists
|
D27.505.696.577.050.100.200.200 |
|
|
Chi-Square Distribution
|
G17.820.300 |
|
|
Cognitive Remediation
|
D000072466 |
[Behavioral treatment that uses drill and practice, compensatory and adaptive strategies to facilitate improvement in targeted learning areas.
] |
|
Integrin alpha4beta1
|
D12.776.395.550.200.625.347 |
|
|
Cytochrome P450 Family 2
|
D000072467 |
[A cytochrome P450 enzyme family that includes members which function in the metabolism of STEROIDS; COUMARINS; and NICOTINE.
] |
|
Tabebuia
|
B01.650.940.800.575.912.250.583.080.500 |
|
|
Selection Bias
|
N05.715.350.150.775 |
|
|
Bias
|
N05.715.350.150 |
|
|
Cytochrome P450 Family 3
|
D000072469 |
[A cytochrome P450 enzyme family that includes members with critical functions in the metabolism of drugs and SEX HORMONES.
] |
|
Bezafibrate
|
D001629 |
[An antilipemic agent that lowers CHOLESTEROL and TRIGLYCERIDES. It decreases LOW DENSITY LIPOPROTEINS and increases HIGH DENSITY LIPOPROTEINS.
] |
|
Iron Regulatory Protein 1
|
D12.776.664.962.374 |
|
|
MicroRNAs
|
D13.444.735.790.552.500 |
|
|
Encephalitis, Varicella Zoster
|
C10.228.228.399.750.400 |
|
|
Czechoslovakia
|
Z01.586.250 |
|
|
Prognathism
|
C07.650.500.460.655 |
|
|
Microscopy, Energy-Filtering Transmission Electron
|
E05.196.867.838.500 |
|
|
Spectroscopy, Electron Energy-Loss
|
E05.196.867.838 |
|
|
Postpoliomyelitis Syndrome
|
C10.574.827 |
|
